0000950170-24-061778.txt : 20240517
0000950170-24-061778.hdr.sgml : 20240517
20240517164748
ACCESSION NUMBER: 0000950170-24-061778
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240516
FILED AS OF DATE: 20240517
DATE AS OF CHANGE: 20240517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nunn Jason Raleigh
CENTRAL INDEX KEY: 0001444319
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 24960690
MAIL ADDRESS:
STREET 1: 1119 ST. PAUL STREET
CITY: BALTIMORE
STATE: MD
ZIP: 21202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4224 CAMPUS POINT COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 4224 CAMPUS POINT COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
ownership.xml
4
X0508
4
2024-05-16
0001505512
Regulus Therapeutics Inc.
RGLS
0001444319
Nunn Jason Raleigh
C/O REGULUS THERAPEUTICS INC.
4224 CAMPUS POINT COURT #210
SAN DIEGO
CA
92121
true
false
false
false
false
Stock Option (Right to Buy)
2.01
2024-05-16
4
A
false
30000
0.00
A
2034-05-15
Common Stock
30000
30000
D
Pursuant to the Company's Non Employee Director's Compensation policy, the options are automatically granted on the date of the Company's Annual Meeting of
Stockholders and will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant or on the date of the
Company's next annual stockholder meeting, whichever occurs first, subject to the Reporting Person's continuous service.
Christopher Aker, Attorney in Fact
2024-05-17